Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON48057
NL-OMON48057
Not yet recruiting
Not Applicable

Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity. - Effect BoNT-A on spasticity.

Stichting Sint Maartenskliniek0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Stichting Sint Maartenskliniek
Enrollment
10
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Stichting Sint Maartenskliniek

Eligibility Criteria

Inclusion Criteria

  • •\- a minimum of 6 months post\-lesion/post\-stroke to ensure that the participant
  • •has a stable neurological condition, without clinical alterations
  • •\- age 18 years or older at the time of the study
  • •\- spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score
  • •\- have an ankle joint range of motion of at least 20° in the sagittal plane
  • •\- ability to make a transfer on to the Achilles (medical device)
  • •\- current treatment of any/all of the m. tricpes surae with BoNT\-A for
  • •spasticity reduction

Exclusion Criteria

  • •\- have a MAS/Tardieu score of 4
  • •\- receive BoNT\-A combined with other therapies aimed at reducing spasticity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticitySpinal Cord Injury and Stroke
NL-OMON26235Sint Maartenskliniek Research10
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42
IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Not yet recruiting
Not Applicable
The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.Diseases of the nervous system
KCT0000530Yonsei University Health System, Severance Hospital30